Vascular Aging & Arterial Health Baseline Panel
A comprehensive cardiovascular baseline panel evaluating ApoB, Lipoprotein (a), hs-CRP, Hemoglobin A1c, lipid profile, metabolic markers, and urinary albumin. Designed to assess vascular aging, arterial health, inflammation, metabolic function, and early kidney stress, this panel supports proactive cardiovascular risk evaluation and long-term heart health monitoring.
- $656.47
- $179
- Save: 72.73%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: Microalbumin Random Urine with Creatinine
Creatinine, Random Urine
Microalbumin
Microalbumin/Creatinine
Apolipoprotein B
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Lipoprotein A, Lp (a), Lp(a)
Lipoprotein (A)
The Vascular Aging & Arterial Health Baseline Panel panel contains 7 tests with 34 biomarkers .
A Comprehensive Baseline for Cardiovascular and Arterial Health
The Vascular Aging & Arterial Health Baseline Panel is a comprehensive blood and urine testing profile designed to evaluate key markers associated with cardiovascular risk, arterial health, metabolic function, inflammation, and early vascular aging. This panel brings together advanced lipid testing, inflammatory markers, glycemic assessment, metabolic evaluation, and kidney health indicators to provide a multidimensional view of cardiometabolic status.
Arterial aging is influenced by a combination of lipid imbalances, chronic inflammation, insulin resistance, oxidative stress, and endothelial dysfunction. Traditional cholesterol testing alone does not always capture the full picture of cardiovascular risk. This panel expands beyond a standard lipid panel by including Apolipoprotein B (ApoB), Lipoprotein (a) [Lp(a)], and high-sensitivity C-reactive protein (hs-CRP)—markers that offer deeper insight into atherosclerotic risk and vascular inflammation.
In addition, Hemoglobin A1c evaluates long-term glucose control, while the Comprehensive Metabolic Panel (CMP) assesses liver function, kidney function, electrolytes, and metabolic balance. The inclusion of Albumin Random Urine with Creatinine provides early detection of kidney stress and microvascular damage, which can be associated with hypertension, diabetes, and vascular disease.
Together, these tests create a structured baseline assessment for individuals and healthcare providers seeking to evaluate arterial health, identify early risk factors for cardiovascular disease, and establish objective markers for ongoing monitoring. This panel is appropriate for baseline risk stratification, preventive health evaluations, and longitudinal cardiometabolic tracking.
When and Why Someone Would Order This Panel
Establishing a Cardiovascular Risk Baseline
This panel is often ordered to establish a comprehensive baseline for cardiovascular and arterial health. Individuals with a family history of heart disease, stroke, or elevated cholesterol may benefit from expanded lipid and inflammatory testing beyond traditional cholesterol measurements. By assessing ApoB and Lipoprotein (a), this panel helps uncover inherited or particle-based risk that may not be evident from LDL cholesterol alone.
Evaluating Risk for Atherosclerosis and Vascular Aging
Atherosclerosis—the gradual buildup of plaque within arteries—is influenced by lipid particle burden, chronic inflammation, blood sugar control, and metabolic health. This panel evaluates all of these domains simultaneously. Elevated ApoB reflects the number of atherogenic lipoprotein particles, while Lp(a) identifies genetically influenced cardiovascular risk. hs-CRP measures low-grade systemic inflammation that may contribute to plaque instability and vascular damage.
Healthcare providers may order this panel when there is concern for early arterial stiffness, subclinical atherosclerosis, or cardiometabolic syndrome.
Monitoring Metabolic and Glycemic Health
Hemoglobin A1c provides insight into average blood glucose levels over approximately three months. Persistent elevations in blood sugar can accelerate vascular aging and increase the risk of coronary artery disease, peripheral artery disease, and microvascular complications. When combined with the Comprehensive Metabolic Panel, providers gain a broader understanding of glucose regulation, electrolyte balance, and organ function.
Assessing Kidney and Microvascular Health
The inclusion of Albumin Random Urine with Creatinine allows for early detection of microalbuminuria—an early marker of kidney stress and endothelial dysfunction. Subtle kidney changes may occur before symptoms develop and can signal increased cardiovascular risk.
Overall, this panel is appropriate for individuals seeking a proactive cardiovascular assessment, those monitoring existing cardiometabolic risk factors, or those working with a healthcare provider on prevention-focused care.
What Does the Panel Measure
Lipid Panel
The Lipid Panel measures:
-
Total Cholesterol
-
LDL Cholesterol
-
HDL Cholesterol
-
Triglycerides
These markers provide a foundational assessment of cholesterol balance and triglyceride levels, which are central to cardiovascular risk evaluation.
Apolipoprotein B (ApoB)
ApoB reflects the total number of atherogenic lipoprotein particles, including LDL and very low-density lipoproteins (VLDL). Because each atherogenic particle contains one ApoB molecule, this test provides a direct measurement of particle burden, offering a more precise risk assessment than LDL cholesterol concentration alone.
Lipoprotein (a) [Lp(a)]
Lp(a) is a genetically determined lipoprotein variant associated with increased risk of atherosclerotic cardiovascular disease and calcific aortic valve disease. Elevated Lp(a) is not significantly altered by lifestyle changes and may identify inherited cardiovascular risk.
High-Sensitivity C-Reactive Protein (hs-CRP)
hs-CRP is a sensitive marker of systemic inflammation. Even low-grade inflammation can contribute to plaque formation and instability, making hs-CRP valuable in assessing inflammatory cardiovascular risk.
Hemoglobin A1c
Hemoglobin A1c reflects average blood glucose levels over the previous 2–3 months. It is used to evaluate glycemic control and identify patterns consistent with prediabetes or diabetes.
Comprehensive Metabolic Panel (CMP)
The CMP evaluates:
-
Liver enzymes
-
Kidney function markers
-
Electrolytes
-
Blood glucose
-
Protein levels
This broad metabolic overview helps identify organ function abnormalities that may influence cardiovascular health.
Albumin Random Urine with Creatinine
This test measures urinary albumin relative to creatinine to assess early kidney damage and microvascular stress. Elevated urinary albumin can indicate endothelial dysfunction and increased cardiovascular risk.
How Patients and Healthcare Providers Use the Results
Identifying Atherosclerotic Cardiovascular Risk
Healthcare providers use ApoB, Lp(a), and lipid results to assess the burden of atherogenic lipoproteins and stratify risk for coronary artery disease, carotid artery disease, and peripheral arterial disease. Elevated ApoB or Lp(a) may prompt more detailed cardiovascular evaluation or lifestyle and therapeutic discussions.
Monitoring Inflammation and Vascular Stability
hs-CRP levels help evaluate systemic inflammation that may influence plaque formation and arterial stiffness. Persistently elevated hs-CRP may support further evaluation of inflammatory contributors to vascular disease.
Evaluating and Managing Metabolic Syndrome
Hemoglobin A1c and triglyceride levels contribute to the assessment of metabolic syndrome—a cluster of conditions including insulin resistance, abdominal obesity, hypertension, and dyslipidemia. Addressing these factors may reduce long-term cardiovascular risk.
Detecting Early Kidney and Microvascular Changes
Elevated urinary albumin can indicate early kidney involvement, particularly in individuals with diabetes or hypertension. Early detection supports timely intervention and risk modification strategies.
Tracking Trends Over Time
This panel is particularly valuable when used longitudinally. Tracking changes in ApoB, A1c, hs-CRP, and urinary albumin over time helps evaluate the effectiveness of dietary changes, exercise, medical therapy, and risk-reduction strategies.
By integrating lipid, inflammatory, glycemic, metabolic, and renal markers, this panel supports a comprehensive, data-driven approach to cardiovascular and vascular health monitoring.
A Structured Approach to Understanding Vascular Aging
The Vascular Aging & Arterial Health Baseline Panel provides a multidimensional evaluation of cardiovascular and metabolic health. Rather than focusing on a single risk marker, it examines lipid particle burden, inherited risk factors, systemic inflammation, blood sugar regulation, organ function, and early kidney stress.
Arterial aging and atherosclerosis develop over time, often without obvious symptoms in early stages. Identifying risk markers early supports informed discussions between patients and healthcare providers about long-term cardiovascular health strategies.
By combining advanced lipid markers with metabolic and inflammatory testing, this panel offers a comprehensive foundation for preventive care, monitoring, and personalized health planning. It serves as an objective starting point for understanding vascular health and tracking changes over time in a clinically meaningful way.